Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 2
2004 4
2005 5
2006 2
2007 2
2008 3
2009 4
2010 2
2012 5
2013 5
2014 10
2015 6
2016 6
2017 7
2018 10
2019 15
2020 51
2021 47
2022 32
2023 20
2024 15
2025 17
2026 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

229 results

Results by year

Filters applied: . Clear all
Page 1
[Artificial intelligence in cardiology: the new HAL 9000?].
Bernardi M, Spadafora L, Dalla Vecchia LA, Pedretti RFE, Cenciarelli S, Zoccai GB, Versaci F. Bernardi M, et al. Among authors: versaci f. G Ital Cardiol (Rome). 2026 Mar;27(3):159-167. doi: 10.1714/4650.46644. G Ital Cardiol (Rome). 2026. PMID: 41738417 Review. Italian.
Magnitude of blood pressure reduction in response to levosimendan infusion independently predicts in-hospital mortality in patients with acute heart failure.
Sarto G, Simeone B, Sbandi F, Valenti V, Forte M, Spadafora L, Bernardi M, Golino M, Tres G, Cantiello G, Frati L, Frati G, Di Mario R, Colaiori I, Biondi-Zoccai G, Versaci F, Sciarretta S. Sarto G, et al. Among authors: versaci f. J Cardiovasc Pharmacol. 2026 Feb 23. doi: 10.1097/FJC.0000000000001811. Online ahead of print. J Cardiovasc Pharmacol. 2026. PMID: 41729537
Vessel-Oriented Analysis on the Relationship Between Quantitative-Flow Ratio and Mortality in Patients With Severe Aortic Stenosis and Intermediate Coronary Lesions.
Colaiori I, Paolucci L, Mangiacapra F, Barbato E, Nardi G, Escaned J, Campo G, Biscaglia S, Versaci F, Biondi-Zoccai G, Gaspardone A, Vitolo M, Benatti G, Vignali L, Boriani G, Guiducci V. Colaiori I, et al. Among authors: versaci f. Catheter Cardiovasc Interv. 2026 Jan 29. doi: 10.1002/ccd.70491. Online ahead of print. Catheter Cardiovasc Interv. 2026. PMID: 41611632
Cardiovascular Safety of Bruton Tyrosine Kinase Inhibitors: From Ibrutinib to Next-Generation Agents.
Spadafora L, Russo F, Bukowska-Olech E, Panichella G, Garofalo M, Cacciatore S, Sabouret P, Sarto G, Simeone B, Rocco E, Lauretti A, Versaci F, Zoccai GB, Colaiori I, Valenti V, Sciarretta S, Bernardi M. Spadafora L, et al. Among authors: versaci f. Am J Cardiovasc Drugs. 2026 Jan;26(1):21-34. doi: 10.1007/s40256-025-00757-6. Epub 2025 Aug 28. Am J Cardiovasc Drugs. 2026. PMID: 40877482 Free PMC article. Review.
Additional Value of Optical Coherence Tomography-Derived Virtual Flow Reserve for Percutaneous Coronary Intervention Guidance.
Marrone A, Erriquez A, Verardi FM, Colaiori I, Cocco M, Caglioni S, Tumscitz C, Penzo C, Marchini F, Meinen J, McNutt J, Buijs JOD, Chiu WC, Versaci F, Campo G, Biscaglia S. Marrone A, et al. Among authors: versaci f. Catheter Cardiovasc Interv. 2025 Dec;106(7):3456-3464. doi: 10.1002/ccd.70207. Epub 2025 Sep 23. Catheter Cardiovasc Interv. 2025. PMID: 40988408
Current Challenges for the Diagnosis of HFpEF and Possible Simplification of the Diagnostic Approach.
Bernardi M, Golino M, Spadafora L, Sarto G, Forte M, Simeone B, Rocco E, Valenti V, Schiavon S, Esposito A, Di Florio E, Scalia L, Lo Sasso L, Frati G, Zoccai GB, Versaci F, Sciarretta S. Bernardi M, et al. Among authors: versaci f. J Cardiovasc Pharmacol. 2025 Dec 1;86(6):522-534. doi: 10.1097/FJC.0000000000001755. J Cardiovasc Pharmacol. 2025. PMID: 40932013 Review.
229 results